CDC25B
Cell division cycle 25B |
---|
PDB rendering based on 1cwr. |
Available structures |
PDB |
Ortholog search: PDBe, RCSB |
List of PDB id codes |
1CWR, 1CWS, 1CWT, 1QB0, 1YM9, 1YMD, 1YMK, 1YML, 1YS0, 2A2K, 2IFD, 2IFV, 2UZQ, 3FQT, 3FQU, 4WH7, 4WH9
|
|
|
Identifiers |
---|
Symbol |
CDC25B |
---|
External IDs |
OMIM: 116949 MGI: 99701 HomoloGene: 41451 ChEMBL: 4804 GeneCards: CDC25B Gene |
---|
EC number |
3.1.3.48 |
---|
|
RNA expression pattern |
---|
|
More reference expression data |
Orthologs |
---|
Species |
Human |
Mouse |
---|
Entrez |
994 |
12531 |
---|
Ensembl |
ENSG00000101224 |
ENSMUSG00000027330 |
---|
UniProt |
P30305 |
P30306 |
---|
RefSeq (mRNA) |
NM_001287516 |
NM_001111075 |
---|
RefSeq (protein) |
NP_001274445 |
NP_001104545 |
---|
Location (UCSC) |
Chr 20: 3.79 – 3.81 Mb |
Chr 2: 131.19 – 131.2 Mb |
---|
PubMed search |
|
|
---|
|
M-phase inducer phosphatase 2 is an enzyme that in humans is encoded by the CDC25B gene.[1]
CDC25B is a member of the CDC25 family of phosphatases. CDC25B activates the cyclin dependent kinase CDC2 by removing two phosphate groups and it is required for entry into mitosis. CDC25B shuttles between the nucleus and the cytoplasm due to nuclear localization and nuclear export signals. The protein is nuclear in the M and G1 phases of the cell cycle and moves to the cytoplasm during S and G2. CDC25B has oncogenic properties, although its role in tumor formation has not been determined. Multiple transcript variants for this gene exist.[2]
Interactions
CDC25B has been shown to interact with MAPK14,[3] Casein kinase 2, alpha 1,[4] CHEK1,[5] MELK,[6] Estrogen receptor alpha,[7] YWHAB,[8][9] YWHAZ,[8] YWHAH[8] and YWHAE.[8][9]
References
Further reading
- Draetta G, Eckstein J (1997). "Cdc25 protein phosphatases in cell proliferation". Biochim. Biophys. Acta 1332 (2): M53–63. doi:10.1016/S0304-419X(96)00049-2. PMID 9141461.
- Nilsson I, Hoffmann I (2000). "Cell cycle regulation by the Cdc25 phosphatase family". Progress in cell cycle research 4: 107–14. doi:10.1007/978-1-4615-4253-7_10. PMID 10740819.
- Nagata A, Igarashi M, Jinno S; et al. (1992). "An additional homolog of the fission yeast cdc25+ gene occurs in humans and is highly expressed in some cancer cells". New Biol. 3 (10): 959–68. PMID 1662986.
- Conklin DS, Galaktionov K, Beach D (1995). "14-3-3 proteins associate with cdc25 phosphatases". Proc. Natl. Acad. Sci. U.S.A. 92 (17): 7892–6. doi:10.1073/pnas.92.17.7892. PMC 41252. PMID 7644510.
- Galaktionov K, Lee AK, Eckstein J; et al. (1995). "CDC25 phosphatases as potential human oncogenes". Science 269 (5230): 1575–7. doi:10.1126/science.7667636. PMID 7667636.
- Demetrick DJ, Beach DH (1994). "Chromosome mapping of human CDC25A and CDC25B phosphatases". Genomics 18 (1): 144–7. doi:10.1006/geno.1993.1440. PMID 8276402.
- Honda R, Ohba Y, Nagata A; et al. (1993). "Dephosphorylation of human p34cdc2 kinase on both Thr-14 and Tyr-15 by human cdc25B phosphatase". FEBS Lett. 318 (3): 331–4. doi:10.1016/0014-5793(93)80540-B. PMID 8440392.
- Lane SA, Baker E, Sutherland GR; et al. (1993). "The human cell cycle gene CDC25B is located at 20p13". Genomics 15 (3): 693–4. doi:10.1006/geno.1993.1129. PMID 8468065.
- Baldin V, Cans C, Superti-Furga G, Ducommun B (1997). "Alternative splicing of the human CDC25B tyrosine phosphatase. Possible implications for growth control?". Oncogene 14 (20): 2485–95. doi:10.1038/sj.onc.1201063. PMID 9188863.
- Booher RN, Holman PS, Fattaey A (1997). "Human Myt1 is a cell cycle-regulated kinase that inhibits Cdc2 but not Cdk2 activity". J. Biol. Chem. 272 (35): 22300–6. doi:10.1074/jbc.272.35.22300. PMID 9268380.
- Sanchez Y, Wong C, Thoma RS; et al. (1997). "Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25". Science 277 (5331): 1497–501. doi:10.1126/science.277.5331.1497. PMID 9278511.
- Jin P, Hardy S, Morgan DO (1998). "Nuclear Localization of Cyclin B1 Controls Mitotic Entry After DNA Damage". J. Cell Biol. 141 (4): 875–85. doi:10.1083/jcb.141.4.875. PMC 2132764. PMID 9585407.
- Hofmann K, Bucher P, Kajava AV (1998). "A model of Cdc25 phosphatase catalytic domain and Cdk-interaction surface based on the presence of a rhodanese homology domain". J. Mol. Biol. 282 (1): 195–208. doi:10.1006/jmbi.1998.1998. PMID 9733650.
- Forrest AR, McCormack AK, DeSouza CP; et al. (1999). "Multiple splicing variants of cdc25B regulate G2/M progression". Biochem. Biophys. Res. Commun. 260 (2): 510–5. doi:10.1006/bbrc.1999.0870. PMID 10403798.
- Karlsson C, Katich S, Hagting A; et al. (1999). "Cdc25b and Cdc25c Differ Markedly in Their Properties as Initiators of Mitosis". J. Cell Biol. 146 (3): 573–84. doi:10.1083/jcb.146.3.573. PMC 2150562. PMID 10444066.
- Reynolds RA, Yem AW, Wolfe CL; et al. (1999). "Crystal structure of the catalytic subunit of Cdc25B required for G2/M phase transition of the cell cycle". J. Mol. Biol. 293 (3): 559–68. doi:10.1006/jmbi.1999.3168. PMID 10543950.
- Mils V, Baldin V, Goubin F; et al. (2000). "Specific interaction between 14-3-3 isoforms and the human CDC25B phosphatase". Oncogene 19 (10): 1257–65. doi:10.1038/sj.onc.1203419. PMID 10713667.
PDB gallery |
---|
| | 1cwr: HUMAN CDC25B CATALYTIC DOMAIN WITHOUT ION IN CATALYTIC SITE |
| 1cws: HUMAN CDC25B CATALYTIC DOMAIN WITH TUNGSTATE |
| 1cwt: HUMAN CDC25B CATALYTIC DOMAIN WITH METHYL MERCURY |
| 1qb0: HUMAN CDC25B CATALYTIC DOMAIN |
| 1ym9: Crystal structure of the CDC25B phosphatase catalytic domain with the active site cysteine in the sulfinic form |
| 1ymd: Crystal Structure of the CDC25B phosphatase catalytic domain with the active site cysteine in the sulfonic form |
| 1ymk: Crystal Structure of the CDC25B phosphatase catalytic domain in the apo form |
| 1yml: Crystal Structure of the CDC25B phosphatase catalytic domain with the active site cysteine in the sulfenic form |
| 1ys0: Crystal Structure of the CDC25B phosphatase catalytic domain with the active site cysteine in the disulfide form |
| 2a2k: Crystal Structure of an active site mutant, C473S, of Cdc25B Phosphatase Catalytic Domain |
| 2ifd: Crystal structure of a remote binding site mutant, R492L, of CDC25B Phosphatase catalytic domain |
| 2ifv: Crystal structure of an active site mutant, C473D, of CDC25B phosphatase catalytic domain |
|
|
|